Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (361-370 of 532) with videos related to

Pageof 54
Sort By:
Oncogene|May 5, 2010
Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cellsG Guo, X Qiu, S Wang, et al.
Psychopharmacology|October 21, 2018
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomesBruce E Blough, Ann M Decker, Antonio Landavazo, et al.
NIDA Research Monograph|January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chlorideJ A Danks, F C Tortella, V Bykov, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphanAkihiro Hashimoto, Arthur E Jacobson, Richard B Rothman, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinansJohannes Schütz, Christina M Dersch, Robert Horel, et al.
Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in miceB Lu, C Ebensperger, Z Dembic, et al.
Neuropharmacology|May 1, 1991
(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulationH Xu, C H Kim, Y C Zhu, et al.
Molecular Pharmacology|February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligandsR B Rothman, A Reid, A Mahboubi, et al.
Pageof 54

Showing results (361-370 of 532) with videos related to

Sort By:
Pageof 54
Oncogene|May 5, 2010
Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cellsG Guo, X Qiu, S Wang, et al.
Psychopharmacology|October 21, 2018
The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomesBruce E Blough, Ann M Decker, Antonio Landavazo, et al.
NIDA Research Monograph|January 1, 1986
Upregulation of the mu-noncompetitive delta binding site by chronic morphine administration: effect of preincubating membranes in 400 nM sodium chlorideJ A Danks, F C Tortella, V Bykov, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeuticsBruce E Blough, Antonio Landavazo, John S Partilla, et al.
Bioorganic & Medicinal Chemistry|August 2, 2002
Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphanAkihiro Hashimoto, Arthur E Jacobson, Richard B Rothman, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and biological evaluation of 14-alkoxymorphinans. 17. Highly delta opioid receptor selective 14-alkoxy-substituted indolo- and benzofuromorphinansJohannes Schütz, Christina M Dersch, Robert Horel, et al.
Journal of Natural Products|February 23, 2011
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin AAnthony Lozama, Christopher W Cunningham, Michael J Caspers, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 1998
Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in miceB Lu, C Ebensperger, Z Dembic, et al.
Neuropharmacology|May 1, 1991
(+)-cis-3-methylfentanyl and its analogs bind pseudoirreversibly to the mu opioid binding site: evidence for pseudoallosteric modulationH Xu, C H Kim, Y C Zhu, et al.
Molecular Pharmacology|February 1, 1991
Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligandsR B Rothman, A Reid, A Mahboubi, et al.
Pageof 54